The PhD in Translational and Molecular Medicine (DIMET) at Università degli Studi di Milano–Bicocca trains researchers to move discoveries from the lab to clinical applications. The programme focuses on molecular mechanisms of disease, translational research methods, and emerging technologies for diagnosis and therapy.
The PhD in Translational and Molecular Medicine (DIMET) at the University of Milano-Bicocca is designed to train researchers in transforming scientific discoveries from laboratory settings into clinical applications. This program emphasizes the understanding of molecular mechanisms underlying diseases, along with advanced translational research methods and innovative technologies for diagnosis and treatment.
The DIMET PhD program offers a blend of structured training and hands-on research, guided by experienced academic and clinical mentors. The curriculum encompasses various thematic areas, supplemented by seminars, journal clubs, and methodological workshops.
Applicants are expected to hold a Master’s degree (second cycle) or an equivalent qualification. Candidates with degrees from older systems or single-cycle second-level degrees may also be considered, depending on the specific program call and evaluation criteria. The selection process takes into account the research alignment and the applicant’s potential contributions to the program's focus on translational and molecular research.
Graduates of the DIMET PhD program are well-equipped for diverse career paths in academia, industry, and healthcare. Potential opportunities include roles in research and development, clinical trials, pharmaceutical companies, biotechnology firms, and academic institutions, where they can contribute to the advancement of medical science and innovative therapies.
Shortlist scholarships and plan your application — free guidance from our advisors.